Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice

Qinyu Wang(Hengyang Academy of Agricultural Sciences), Rong Qi(Sinopec (China))
British Journal of Pharmacology
November 23, 2019
Cited by 288


Related Papers